´º½ºÁ¦¾à¡¤À¯Åë |
ÃÖº´Ã¶¾à»çÀÇ ÁÖ¿äÁúȯ ó¹æ»ç·Ê 23 - ½ÉÀåÆǸ·Áõ(Heart valvular disease) hpharm(¾à±¹½Å¹®) |
|
¾Æ¸·½º Á¤, À¯ÇÑ»çÀ̳ª¹Ìµå)
*Ä¡¾ÆÀÚÀ̵åÀÌ´¢Á¦(Thiazide diu-retics)
¤ýHydrochlorothiazide(´ÙÀÌÅ©·Î¡ Á¤, À¯ÇÑ)
¤ýIndapamide(³ªÆ®¸¯½º Á¤, ÇÑÀÏ)
¤ýTripamide(Æ®¸®Æĸô Á¤, ÇÑÀÏ)
¤ýXipamide(µðÀ¯·º»ê Á¤, ºÎ±¤)
¤ýº¥µð°ï Á¤(¹ÙÀÌ¿¤, mefruside + re-serpine ¿Ü)
*°·ÂÀÌ´¢Á¦(Loop diuretics or Potent diuretics)
¤ýAzosemide(À¯·¹Æ¾ Á¤, »ïÁø)
¤ýBimetanide(ºÎ¸ÞŸ³ªÀ̵å Á¤, ¸ÞµðÄ«ÄÚ¸®¾Æ)
¤ýFurosemide(¶ó½Ä½º Á¤, Çѵ¶)
¤ýPiretanide(¾Æ·¹¸¯½º Ä°¼¿, Çѵ¶) Initially
¤ýTorasemide(Åä·½ Á¤, Çѱ¹·Î½´)
*Ä®·ýº¸±ÞÀÌ´¢Á¦(K-sparing diuretics)
¤ýAmilorde(¾Æ¹Ì·Î Á¤, °ÇÀÏ)
¤ýSpironolactone(ÀÏ´ÚÅæ Á¤, Çѱ¹½ä)
¤ýTriamterene(Å׸®¾È Á¤, »ï¿ì)
¤ý¾Ë´ÚŸÀÚÀ̵å Á¤(Çѱ¹½ä, spironolactone+HCTZ)
*»ïÅõ¾ÐÀÌ´¢Á¦(Osmotic diuretics)
¤ýManitol(¸¸´ÏÅç ÁÖ, ´ëÇÑ)
*±âŸÀÌ´¢Á¦
¤ýCicletanine(ÅÙ½ºÅ¸ÅÙ Ä°¼¿, ´ë¿õ)
¤ýFenquizone(ÇÏÀ̵à·Ð ¿¬ÁúÄ°¼¿, »ïÀÏ)
<°½ÉÁ¦ positive inotropic agents>
*Na, K-ATPase ÀúÇØÁ¦(Na, K-ATPase inhibitors)
¤ýDigoxin(¶ó³ì½ÅÁ¤, ÁÖ, ¿¤¸¯»ç, »ïÀÏ)
¤ýB-Methyldigoxin(¶ó´ÏÅé Á¤, Á¾±Ù´ç)
*c-AMP Æ÷½ºÆ÷µð¿¡½ºÅ׶óÁ¦ ÀúÇØÁ¦(c-AMP phosphodiesterase inhibi-tors)
¤ýAmrinone(À̳ëÄÚ ÁÖ, »ç³ëÇÇ-½ÅÅ׶óº¸ÄÚ¸®¾Æ)
¤ýMilrinone(ÇÁ¸®¸¶ÄÚ ÁÖ, »ç³ëÇÇ-½Åµ¥¶óº¸ÄÚ¸®¾Æ)
¤ýPerindopril tert-butylamine(¾Æ¼Æ¿ Á¤, Çѱ¹¼¼¸£ºñ¿¡)
¤ýTemocalril(¿¡À̽ºÄÝ Á¤, µ¿È)
<¾ÈÁö¿ÀÅٽżö¿ëü ±æÇ×Á¦ Angiote-nsin II receptor antagonists, AII-RAs>
¤ýCandesartan(¾ÆŸ°£ Á¤, ¾Æ½ºÆ®¶óÁ¦³×Ä«)
¤ýEprosartan(Å׺ñÅÙ Á¤, Çѱ¹ÈÀÌÀÚ)
¤ýIrbesartan(¾ÆÇÁ·Îº§ Á¤, »ç³ëÇÇ-½Åµ¥¶óº¸ÄÚ¸®¾Æ)
¤ýLosartan(ÄÚÀÚ Á¤, Çѱ¹MSD)
¤ýValsartan(µð¿À¹Ý Ä°¼¿, Çѱ¹³ë¹ÙƼ½º)
¤ýÇÏÀÌÀÚ Á¤(Çѱ¹MSD, losartan+h-ydrochlorothiazide)
<Ä®·ýä³Î°³¹æÁ¦ Potassium chan-nel opener>
¤ýNicorandil(½Ã±×¸¶Æ® Á¤, Áß¿Ü)
<±³°¨½Å°æ´º·ÐÂ÷´ÜÁ¦ Adrenergic n-euron blockers>
¤ýResepepine(ºÎ±¤ ·¹¼¿ÇÉ Á¤)
< ÀúÀÛ±ÇÀÚ © ¾à±¹½Å¹® ¹«´ÜÀüÀç ¹× Àç¹èÆ÷±ÝÁö > |
|
|
|
|
ÀÌ ±â»ç¿¡ ´ëÇÑ ´ñ±Û À̾߱â (0) |
|
|
|